EMPHYSEMATOUS CHOLECYSTITIS

EMPHYSEMATOUS CHOLECYSTITIS was reported 50 times

EMPHYSEMATOUS CHOLECYSTITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 BCL-2 Inhibitor [EPC] 13 0.0002
1 Tetracycline-class Antibacterial [EPC] 1 0.0001
2 Lipopeptide Antibacterial [EPC] 1 0.0001
3 Janus Kinase Inhibitor [EPC] 13 0.0001
4 GLP-2 Analog [EPC] 1 0.0001
5 Penem Antibacterial [EPC] 2 0.0001
6 Alkylating Drug [EPC] 14 0.0001
7 Nucleoside Metabolic Inhibitor [EPC] 13 0.0000
8 Bile Acid [EPC] 1 0.0000
9 CD20-directed Cytolytic Antibody [EPC] 13 0.0000
10 Sympathomimetic-like Agent [EPC] 1 0.0000
11 Glycopeptide Antibacterial [EPC] 2 0.0000
12 Nitroimidazole Antimicrobial [EPC] 2 0.0000
13 Kinase Inhibitor [EPC] 13 0.0000
14 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
15 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
16 Corticosteroid [EPC] 19 0.0000
17 Prostacycline Vasodilator [EPC] 2 0.0000
18 Microtubule Inhibitor [EPC] 2 0.0000
19 Platinum-based Drug [EPC] 3 0.0000
20 Endothelin Receptor Antagonist [EPC] 2 0.0000
21 Aminosalicylate [EPC] 1 0.0000
22 Interleukin-23 Antagonist [EPC] 1 0.0000
23 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
24 alpha-Adrenergic Blocker [EPC] 1 0.0000
25 Azole Antifungal [EPC] 1 0.0000
26 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
27 Thiazide Diuretic [EPC] 1 0.0000
28 GLP-1 Receptor Agonist [EPC] 2 0.0000
29 Opioid Agonist [EPC] 1 0.0000
30 Factor Xa Inhibitor [EPC] 1 0.0000
31 Osmotic Laxative [EPC] 1 0.0000
32 beta-Adrenergic Blocker [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
34 Insulin Analog [EPC] 1 0.0000
35 Loop Diuretic [EPC] 1 0.0000
36 Platelet Aggregation Inhibitor [EPC] 1 0.0000